GH axis
CJC-1295 (no DAC)
Modified GRF(1-29)
Growth hormone releasing hormone analog
A tetrasubstituted analog of GHRH(1-29) engineered for metabolic stability. Widely used in preclinical research on pulsatile growth hormone release.
For laboratory research use only. Not for human or animal consumption, not a drug, food, cosmetic, or supplement. By adding to cart, the researcher affirms compliance with all applicable regulations.
Vial size
Research price
$39
SKU VRL-CJC-5
Ships cold-chain · Lot VRL-CJC-2602 · Checkout secured by Waave
Specifications
CJC-1295 without DAC, also referred to as Modified GRF(1-29), is a synthetic analog of the first 29 amino acids of endogenous GHRH, with substitutions (D-Ala², Gln⁸, Ala¹⁵, Leu²⁷) that confer resistance to proteolytic cleavage.
Published preclinical and early clinical literature has investigated the peptide's action at the pituitary GHRH receptor and its influence on pulsatile GH release in animal models and healthy human volunteers.
The peptide is commonly used in laboratory settings to interrogate GH axis physiology, often paired with a GH secretagogue such as Ipamorelin in dual-stimulation research protocols.
Related research tools
